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Stroke care based on evidence of clinical effectiveness (eg, access to stroke specialists, rapid scanning, assessment, treat-
ments, and therapies, referred to here as evidence-based clini-
cal interventions) is associated with better patient outcomes.1–5 
Benefits include reductions in mortality, length of stay, and dis-
ability and increases in independence and quality of life.
Some health systems have centralized their stroke ser-
vices to create a smaller number of high volume specialist 
Background and Purpose—In 2010, Greater Manchester and London centralized acute stroke care into hyperacute units 
(Greater Manchester=3, London=8), with additional units providing ongoing specialist stroke care nearer patients’ homes. 
Greater Manchester patients presenting within 4 hours of symptom onset were eligible for hyperacute unit admission; all 
London patients were eligible. Research indicates that postcentralization, only London’s stroke mortality fell significantly 
more than elsewhere in England. This article attempts to explain this difference by analyzing how centralization affects 
provision of evidence-based clinical interventions.
Methods—Controlled before and after analysis was conducted, using national audit data covering Greater Manchester, 
London, and a noncentralized urban comparator (38 623 adult stroke patients, April 2008 to December 2012). Likelihood 
of receiving all interventions measured reliably in pre- and postcentralization audits (brain scan; stroke unit admission; 
receiving antiplatelet; physiotherapist, nutrition, and swallow assessments) was calculated, adjusting for age, sex, stroke-
type, consciousness, and whether stroke occurred in-hospital.
Results—Postcentralization, likelihood of receiving interventions increased in all areas. London patients were overall significantly 
more likely to receive interventions, for example, brain scan within 3 hours: Greater Manchester=65.2% (95% confidence 
interval=64.3–66.2); London=72.1% (71.4–72.8); comparator=55.5% (54.8–56.3). Hyperacute units were significantly more 
likely to provide interventions, but fewer Greater Manchester patients were admitted to these (Greater Manchester=39%; 
London=93%). Differences resulted from contrasting hyperacute unit referral criteria and how reliably they were followed.
Conclusions—Centralized systems admitting all stroke patients to hyperacute units, as in London, are significantly more 
likely to provide evidence-based clinical interventions. This may help explain previous research showing better outcomes 
associated with fully centralized models.   (Stroke. 2015;46:2244-2251. DOI: 10.1161/STROKEAHA.115.009723.)
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services, aiming to improve patient access to evidence-based 
clinical interventions.6–9 Recent research indicates that dif-
ferent models of centralization are associated with different 
outcomes.4 However, the mechanisms underlying this effect 
are unclear. This article attempts to explain the differences in 
clinical outcomes by analyzing the impact of 2 different mod-
els of centralization on provision of evidence-based clinical 
interventions.
In 2010, stroke services in Greater Manchester (popu-
lation 2.68 million people10) and London (population 8.17 
million people10) were centralized, with the intention of 
addressing significant variations in care, whereby many stroke 
patients did not receive evidence-based clinical interven-
tions.11,12 There was little evidence about how best to ensure 
stroke patients receive the full range of interventions, and 
though centralization had been proposed for large metropoli-
tan areas,13 there was little evidence about how best to cen-
tralize stroke services. Consequently, Greater Manchester and 
London selected significantly different models of centraliza-
tion, reflecting local priorities and stakeholder preferences, for 
example, in relation to equitable and timely access to services, 
patient safety, and resource use.
Pre centralization, suspected stroke patients were taken to 
the nearest hospital admitting acute stroke patients: there were 
12 such hospitals in Greater Manchester and 30 in London, 
providing a variety of acute and rehabilitation stroke services 
(see Figure 1).3,4 In each area, stroke services were centralized 
into a small number of hyperacute stroke units providing care 
over the first 72 hours after stroke, including assessment by 
specialized stroke medical teams, brain imaging, and throm-
bolysis, if appropriate; a larger number of units provided 
ongoing specialist stroke care nearer to patients’ homes. A 
major difference between the 2 areas concerned eligibility cri-
teria for hyperacute unit admission. In Greater Manchester, 
patients presenting within 4 hours of developing symptoms 
were eligible for admission to 1 of 3 hyperacute units: a 
Comprehensive Stroke Center, admitting patients at any time, 
and 1 Primary Stroke Centres (PSCs), admitting patients 7 am 
to 7 pm, Monday to Friday (Figure 1A). Patients presenting 
outside 4 hours were admitted to their nearest District Stroke 
Center (DSC), which provided all aspects of acute stroke care 
required beyond the first 4 hours; out of hours, PSCs operated 
a DSC service. In London, all stroke patients were eligible for 
treatment in 1 of 8 Hyperacute Stroke Units (HASUs), which 
admitted stroke patients at any time, and provided the first 72 
hours of care; patients were then transferred to the community 
or to 1 of 24 Stroke Units (SUs), which provided acute reha-
bilitation services until patients were ready to return to the 
community (Figure 1B). The contrasting models represent an 
opportunity to analyze different centralization models.
Recent research indicates that although both Greater 
Manchester and London centralizations were associated with 
significantly greater reductions in length of stay, only the 
London centralization was associated with a significantly 
greater reduction in stroke patient mortality than in the rest of 
England.4 In this article, we examine whether this important 
difference in outcomes can be explained by (1) the impact of 
centralizations on provision of evidence-based clinical inter-
ventions and (2) differences between the Greater Manchester 
and London models’ eligibility criteria for admission to hyper-
acute unit and how reliably these criteria were followed.
Methods
Design
This study used a controlled before and after design. It analyzed 
risk-adjusted likelihood of stroke patients receiving evidence-based 
clinical interventions in Greater Manchester and London, pre- and 
postcentralization, compared with urban areas of England where 
acute stroke services had not been centralized (hereafter referred to 
as the ‘comparator’).
Data
Patient-level data were drawn from 2 national audits organized by the 
Royal College of Physicians: precentralization, the National Sentinel 
Stroke Clinical Audit, conducted from April to August 2008, was used; 
postcentralization, the Stroke Improvement National Audit Program 
(SINAP), which ran from April 2010 to December 2012,14,15 was used. 
Reflecting the implementation dates for the centralizations, the Greater 
Manchester postcentralization period was April 2010 to December 
2012 inclusive, whereas London’s was July 2010 to December 2012 
inclusive. Data collected in the 2 audits differed: Sentinel 2008 col-
lected a snapshot of ≤60 patients per participating stroke service, 
whereas SINAP collected data for all patients receiving stroke care. 
Consequently, postcentralization data cover significantly more patients.
The analysis included data submitted by all hospitals providing 
acute stroke care in Greater Manchester, London, and a compara-
tor area formed of hospitals providing acute stroke care in 2 parts of 
England (North West England, excluding Greater Manchester, and 
North East England), where local documents showed no equivalent 
Figure 1. Simplified summary of stroke service 
models pre- and postcentralization. A, Both areas, 
precentralization. B, Greater Manchester, post-
centralization. C, London, postcentralization. CSC 
indicates Comprehensive Stroke Center, Greater 
Manchester; DSC, District Stroke Center, Greater 
Manchester; HASU, Hyperacute Stroke Unit, Lon-
don; PSC, Primary Stroke Center, Greater Man-
chester; Stroke unit/ward, precentralization stroke 
unit, combining acute and rehabilitation functions; 
and SU, Stroke Unit, London.
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centralization had occurred. The comparator was limited to hospitals 
in urban settings equivalent to Greater Manchester and London (clas-
sified as major urban by the UK Office for National Statistics16); it 
covered 1.8 million people,10 and its level of participation in national 
audits was equivalent to Greater Manchester and London (details 
available in the online-only Data Supplement). Although Sentinel 
2008 had uniformly high participation across England,14 participa-
tion in SINAP was variable in several areas of England, with many 
hospitals submitting little or no data.15 These differing participation 
levels meant the rest of England could not act as the comparator. 
Consequently, data for ≈56 100 stroke patients (7300 before, 48 700 
after) were excluded. Data for all patients diagnosed with stroke (in-
tracerebral hemorrhage or cerebral infarction) were included, both 
those occurring in-hospital and outside hospital. Patients with invalid 
data were excluded.
Measures
We analyzed all evidence-based clinical interventions that had been 
measured consistently in both audits.17,18 These measures were calcu-
lated from arrival at hospital (or symptom-onset if occurring in-hos-
pital) and assessed whether patients had their first brain scan within 3 
and 24 hours of arrival (cut-off points identified in the baseline audit 
national report reflecting time to scan to support administration of 
thrombolysis, and national guidance to scan within 24 hours14); were 
admitted to a stroke unit within 4 hours; received antiplatelet within 
48 hours (if ischemic); and underwent physiotherapist, nutrition, and 
formal swallow assessments within 72 hours (all if eligible).
Statistical Analysis
Descriptive Statistics
Descriptive data were calculated at regional level for Greater 
Manchester, London, and the comparator, pre- and postcentralization. 
Postcentralization, we categorized hospitals based on whether they were 
designated to provide hyperacute care. Consistent data were available 
on patient characteristics (age, sex, stroke type, worst level of conscious-
ness, and whether the stroke occurred within or outside hospital) and 
the proportion of patients receiving each clinical intervention analysed.
Hospital-Level Variation
To understand the impact of the centralizations on patient volume and 
provision of care at hospital level, the unadjusted proportion of pa-
tients receiving evidence-based clinical interventions was calculated 
at hospital level for each area, pre- and postcentralization. Hospital-
level proportions were plotted against the mean number of stroke 
patients submitted to the audits per day and categorized by whether 
services were hyperacute.
Risk-Adjusted Likelihood of Receiving Evidence-Based 
Clinical Interventions
Using patient-level data, we used logistic regression to analyze 
whether patients received each evidence-based clinical interven-
tion (yes/no) against region (whether they were treated in Greater 
Manchester or London [with the comparator as the reference catego-
ry]), time period (whether they were treated in the after period [with 
being treated in the before period as the reference category]), and an 
interaction term between region and time period, controlling for age 
(in 5 year bands), sex, stroke diagnosis (intracerebral hemorrhage/ce-
rebral infarction), worst level of consciousness (fully conscious/semi-
conscious/drowsy/unconscious), and whether stroke occurred within 
or outside hospital (yes/no). All outcomes were binary (yes/no). We 
report marginal effects showing the adjusted predicted probability of 
each outcome in each region in each time period. Because the Greater 
Manchester and London centralizations had different after periods 
(meaning the comparator data differed slightly), the regression analy-
ses of the 2 centralizations were conducted separately. We reran our 
models stratifying by whether the patient was treated in a hyperacute 
or a nonhyperacute stroke service.
Following Referral Criteria for Admission to Hyperacute 
Units in Greater Manchester and London
The proportion of patients treated in a hyperacute stroke unit was 
calculated to examine whether the models selected in Greater 
Manchester and London influenced the likelihood of receiving evi-
dence-based clinical interventions; this was also used to measure how 
reliably the London hyperacute referral criteria were followed. To 
examine how reliably Greater Manchester hyperacute referral criteria 
were followed, we compared patients’ time of symptom onset with 
time of arrival at hospital to calculate the proportion of patients who 
arrived at hospital within 4 hours of symptoms developing (and were 
thus eligible for hyperacute unit admission) and who were in fact 
admitted to a hyperacute unit.
Ethical Approval
This study received ethical approval in September 2011 from the 
London East National Health Service (NHS) Research Ethics 
Committee (Ref 11/LO/1396).
Results
Descriptive Statistics
Data for 38 623 acute stroke cases submitted to national 
audit were analyzed, covering 51 hospitals precentralization 
(from a total of 189 hospitals participating in the audit across 
England) and 44 hospitals postcentralization (from a total of 
171 hospitals across England). Table 1 presents unadjusted 
data for Greater Manchester and London compared with the 
comparator. Patient characteristics were similar in Greater 
Manchester, London, and the comparator in both pre- and 
postcentralization time periods, and any potential effects of 
patient characteristics were controlled for in the regression 
analyses. Postcentralization, the proportion of patients receiv-
ing evidence-based clinical interventions increased in all 3 
areas. It should be noted that denominators for these indi-
cators varied from measure to measure because of variable 
eligibility of patients or availability of data. Increases were 
most pronounced in care provided in the first hours follow-
ing arrival at hospital (brain scan within 3 hours, admitted to 
stroke unit within 4 hours). The proportion of stroke patients 
receiving these clinical interventions was higher in London 
than in Greater Manchester and the comparator, both pre- 
and postcentralization, but the absolute difference was simi-
lar. Proportions of patients receiving evidence-based clinical 
interventions 24 to 72 hours after admission also increased in 
all 3 areas, but in all areas precentralization levels commonly 
exceeded 80% and postcentralization all proportions exceeded 
90%. Generally, London had higher precentralization levels, 
and postcentralization levels were similar—approaching the 
maximum—in each area.
Hospital-Level Variation
Precentralization, there was substantial between-hospital 
variation in the proportion of patients receiving evidence-
based clinical interventions in all 3 areas (Figure 2; online-
only Data Supplement). Postcentralization, hyperacute units 
in Greater Manchester (Comprehensive Stroke Center, PSCs) 
and London (HASUs) treated a higher volume of patients 
than elsewhere (Table 1) and provided evidence-based clinical 
interventions to a higher proportion of their patients (Figure 3; 
and online-only Data Supplement).
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Although the proportion of patients receiving evidence-
based clinical interventions increased in Greater Manchester 
and London’s nonhyperacute units and in the comparator area 
overall, patient volume increased less, and the proportion 
of patients receiving evidence-based clinical interventions 
tended to be lower and more variable than in the hyperacute 
units. When Greater Manchester PSCs operated as DSCs, they 
performed in line with other DSCs (Figure 3A).
Risk-Adjusted Likelihood of Receiving Evidence-
Based Clinical Interventions
Trends in risk-adjusted proportions of patients receiving 
evidence-based clinical interventions reflect the unadjusted 
findings (Tables 2 and 3). Postcentralization, on all clinical 
interventions analyzed, London patients were overall sig-
nificantly more likely to receive clinical interventions than 
comparator patients. Greater Manchester patients were sig-
nificantly more likely than comparator patients to receive 
2 interventions (brain scan within 3 and 24 hours), signifi-
cantly less likely to receive 3 interventions (admission to 
stroke unit within 4 hours and physiotherapist and swallow 
assessments within 72 hours), with no significant difference 
between Greater Manchester and comparator patients on 
the 2 remaining interventions. London patients were overall 
significantly more likely than Greater Manchester patients 
to receive 6 of the 7 interventions (brain scan within 3 and 
24 hours, admission to stroke unit within 4 hours, and phys-
iotherapist, nutrition, and swallow assessments within 72 
Table 1. Patient Characteristics and Unadjusted Proportions of Patients Receiving Evidence-Based Clinical Interventions
Greater Manchester London Comparator
Before After Before After Before After
Total patients (N) 653 10 295 1541 16 553 537 9044
Total hospitals 12 11 30 24 9 9
Case/d rate 0.63 0.97 0.58 1.03 0.80 1.07
HASU case/d rate 1.37 2.17
Non-HASU case/d rate 0.65 0.12
Mean age, y 74.5 73.2 73.3 72.7 74.6 73.6
Proportion >75 y 55% 50% 51% 50% 53% 51%
Proportion female 52% 51% 50% 49% 52% 51%
Stroke type
  Hemorrhage 13% 11% 14% 11% 11% 11%
  Infarct 87% 89% 86% 89% 89% 89%
Worst consciousness
  Fully conscious 60% 74% 67% 78% 68% 75%
  Semi-conscious 19% 15% 17% 15% 11% 14%
  Drowsy 8% 4% 7% 3% 9% 5%
  Unconscious 13% 7% 9% 4% 12% 6%
Patients admitted from 
outside hospital 96% 90% 93% 95% 95% 94%
Patients treated in 
hyperacute unit … 4022/10 295 (39%) … 15 398/16 533 (93%) … …
<4 h patients treated in 
hyperacute unit …   2170/3259 (66.6%) …   5314/5525 (96%) … …
>4 h patients treated in 
hyperacute unit …  869/2154 (40%) …   3514/3697 (95%) … …
Patients where time of 
onset unknown … 4882 … 7311 … …
Interventions
  Brain scan 3 h 98/461 (21%) 5785/10 295 (56%) 496/1353 (37%) 11 614/16 553 (70%) 127/461 (28%) 4902/9044 (54%)
  Stroke Unit 4 h 93/648 (14%) 4982/10 295 (48%) 461/1527 (30%) 11 360/16 553 (69%) 121/536 (23%) 5027/9044 (56%)
  Brain scan 24 h 396/586 (68%) 8814/9563 (92%) 1099/1425 (77%) 14 895/15 679 (95%) 315/506 (62%) 8008/8787 (91%)
  Antiplatelet 48 h 452/529 (85%) 8226/8803 (93%) 1169/1240 (94%) 13 062/13 773 (95%) 375/436 (86%) 7070/7522 (94%)
  Physio 72 h 480/556 (86%) 8030/8867 (91%) 1206/1337 (90%) 14 190/14 760 (96%) 380/440 (86%) 7703/8155 (94%)
  Nutrition 72 h 504/583 (86%) 9308/9918 (94%) 1022/1402 (73%) 15 745/16 021 (98%) 398/479 (83%) 7977/8560 (93%)
  Swallow 72 h 252/304 (83%) 8521/9388 (91%) 698/803 (87%) 15 431/15 684 (98%) 229/263 (87%) 7034/7509 (94%)
Patients treated in hospitals hosting PSCs are categorized as treated in PSC if admitted 7 am–7 pm, Monday to Friday; out of hours, patients are categorized as treated 
in a DSC. Varying denominators for clinical interventions reflect eligibility of patients and availability of data. All interventions are timed from arrival at hospital (or 
symptom-onset if occurring in-hospital). DSC indicates District Stroke Center; HASU, Hyperacute Stroke Units; and PSC, Primary Stroke Centres.
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hours, with magnitude of differences ranging from 1.2% to 
10.4%, with no significant difference on antiplatelet within 48 
hours). Patients treated in hyperacute units, in both Greater 
Manchester and London, were significantly more likely to 
receive clinical interventions than patients treated either in 
nonhyperacute units or in the comparator (with one exception, 
where comparator patients were significantly more likely to 
receive physiotherapist assessment than Greater Manchester 
Figure 2. Between-hospital variations in proportion of patients admitted to stroke unit within 4 hours by area, precentralization. A, Greater 
Manchester, precentralization. B, London, precentralization. C, Comparator, precentralization. Data shown for one clinical intervention: online 
supplement presents the other interventions. Each point represents a hospital: x axis represents mean number of patients submitted to 
audit per day; y axis represents percentage of patients receiving clinical intervention. In London plots, 9 hospitals are categorized as HASUs: 
whereas London had an 8-HASU model, 1 HASU needed time to develop. It began admitting patients from May 2011 and fully operational 
from October 2011. Another hospital provided interim HASU services July 2010 to October 2011. HASU indicates Hyperacute Stroke Units.
Figure 3. Between-hospital variations in proportion of patients admitted to stroke unit within 4 hours by area, postcentralization. A, 
Greater Manchester, postcentralization. B, London, postcentralization. C, Comparator, postcentralization.
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hyperacute patients). Patients treated in Greater Manchester 
hyperacute units were significantly more likely than London 
HASU patients to receive 4 clinical interventions: brain scan 
within 3 hours, admission to stroke unit within 4 hours, brain 
scan within 24 hours, and antiplatelet within 48 hours (the 
magnitude of the differences ranged from 2.0% to 13.8%). 
Patients treated in Greater Manchester hyperacute units were 
significantly less likely to receive physiotherapist assessment 
within 72 hours than patients treated in London HASUs (mag-
nitude 2.2%). There was no significant difference between 
Greater Manchester and London hyperacute units on patients 
receiving nutrition and formal swallow assessments within 
72 hours. To examine whether these differences reflected the 
greater proportion of patients in Greater Manchester arriving 
within 4 hours, we reran this analysis focusing only on patients 
presenting within 4 hours of symptom onset and found the dif-
ferences between Greater Manchester and London hyperacute 
units reduced substantially (see online-only Data Supplement).
Access to Care in Hyperacute Units in Greater 
Manchester and London
Postcentralization, while 39% of Greater Manchester patients 
were treated in a hyperacute unit, 93% of London patients 
were (Table 1). This is explained in part by the different eli-
gibility criteria for admission to hyperacute units in Greater 
Manchester and London. However, in addition, only 66% of 
Greater Manchester stroke patients who presented within 4 
hours of symptom onset were admitted to a hyperacute unit 
(Table 1), meaning 34% of patients who were eligible for 
hyperacute unit care were not admitted to one. This result was 
in line with an analysis conducted by the Greater Manchester 
and Cheshire Cardiac and Stroke Network as part of their 
12-month review of the centralization.11
We reran our analyses using all available data for the 
rest of England as the comparator: the results did not change 
appreciably (see online-only Data Supplement).
Discussion
Postcentralization, risk-adjusted likelihood of patients 
receiving evidence-based clinical interventions increased 
significantly in all areas. London patients were overall sig-
nificantly more likely than patients elsewhere to receive the 
interventions. Importantly, hyperacute units in both Greater 
Manchester and London were significantly more likely to pro-
vide interventions than nonhyperacute units in these areas and 
in the comparator area overall.
Fewer than 40% of Greater Manchester patients were 
admitted to a hyperacute unit, whereas 93% of London 
patients were: this is likely to explain the overall differences 
in provision over the 2 areas and suggests a clear effect of 
Table 3. Risk-Adjusted Proportions of Patients Receiving Evidence-Based Clinical Interventions: London Versus Comparator
Intervention
London (% Likelihood [95% Confidence Intervals])
ComparatorOverall HASUs SUs
Before After After After Before After
Brain scan 3 h 36.5% [34.0–39.1] 72.1% [71.4–72.8] 74.6% [73.8–75.3] 39.9% [36.9–42.9] 21.5% [18.9–24.0] 55.5% [54.8–56.3]
Stroke Unit 4 h 29.6% [27.3–31.9] 66.3% [65.6–67.1] 69.1% [68.3–69.9] 28.6% [25.8–31.3] 18.7% [16.4–21.0] 54.4% [53.6–55.1]
Brain scan 24 h 77.9% [75.8–80.0] 95.2% [94.8–95.5] 96.2% [95.9–96.5] 83.4% [81.3–85.6] 62.4% [59.4–65.3] 91.5% [91.1–92.0]
Antiplatelet 48 h 94.1% [92.8–95.4] 94.8% [94.4–95.2] 95.3% [94.9–95.7] 89.6% [87.7–91.6] 85.4% [83.2–87.6] 93.8% [93.4–94.2]
Physio 72 h 88.9% [87.0–90.7] 95.4% [95.0–95.8] 96.0% [95.6–96.4] 86.3% [83.8–88.7] 87.9% [85.9–89.8] 93.4% [93.0–93.8]
Nutrition 72 h 74.1% [71.7–76.4] 98.3% [98.1–98.5] 98.6% [98.4–98.8] 94.7% [93.4–96.0] 84.2% [81.9–86.4] 93.3% [92.9–93.7]
Swallow 72 h 85.4% [82.8–88.0] 98.2% [97.9–98.4] 99.0% [98.8–99.1] 86.0% [83.6–88.5] 85.4% [82.5–88.3] 92.8% [92.4–93.3]
HASU indicates Hyperacute Stroke Units; and SU, Stroke Unit.
Table 2. Risk-Adjusted Proportions of Patients Receiving Evidence-Based Clinical Interventions: Greater Manchester Versus 
Comparator
Intervention
Greater Manchester (% Likelihood [95% Confidence Intervals])
ComparatorOverall CSC/PSCs DSCs
Before After After After Before After
Brain scan 3 h 25.0% [21.0–29.0] 65.2% [64.3–66.2] 85.5% [84.6–86.5] 52.2% [50.8–53.5] 29.0% [27.1–31.0] 62.3% [61.7–63.0]
Stroke Unit 4 h 17.8% [14.6–21.0] 55.9% [54.9–57.0] 82.9% [81.8–83.9] 36.7% [35.3–38.1] 25.8% [24.0–27.7] 61.1% [60.5–61.7]
Brain scan 24 h 71.7% [68.2–75.1] 94.0% [93.5–94.4] 98.2% [97.8–98.5] 91.6% [90.9–92.2] 69.4% [67.2–71.5] 92.9% [92.5–93.2]
Antiplatelet 48 h 86.5% [83.8–89.2] 94.2% [93.7–94.7] 97.6% [97.1–98.1] 92.2% [91.5–93.0] 91.3% [90.0–92.7] 94.3% [93.9–94.6]
Physio 72 h 88.3% [85.7–90.8] 92.1% [91.5–92.7] 93.8% [93.0–94.7] 91.4% [90.7–92.2] 88.2% [86.6–89.8] 95.2% [94.9–95.5]
Nutrition 72 h 89.9% [87.7–92.0] 95.6% [95.3–96.0] 98.5% [98.2–98.8] 94.1% [93.6–94.7] 70.8% [68.6–73.0] 95.8% [95.5–96.1]
Swallow 72 h 87.7% [84.6–90.9] 94.0% [93.6–94.4] 98.6% [98.2–98.9] 91.6% [90.9–92.2] 82.3% [79.7–84.9] 96.0% [95.7–96.3]
Patients treated in hospitals hosting PSCs are categorized as treated in PSC if admitted 7 am–7 pm, Monday to Friday; out of hours, patients are categorized as treated 
in DSC. All interventions are timed from arrival at hospital (or symptom-onset if occurring in-hospital). CSC indicates Comprehensive Stroke Center; DSC, District Stroke 
Center; and PSC, Primary Stroke Centres.
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the models selected. This effect partly relates to the different 
eligibility criteria for admission to hyperacute unit: in Greater 
Manchester, only stroke patients presenting within 4 hours 
of developing symptoms were eligible, whereas all London 
stroke patients were. However, in Greater Manchester, only 
two thirds of patients eligible for care in a hyperacute unit 
were admitted to one; this suggests that differences between 
Greater Manchester and London derived not only from the 
eligibility criteria, but also from how reliably they were fol-
lowed, with both contributing to the lower overall likelihood 
of patients receiving interventions in Greater Manchester. The 
fact that Greater Manchester hyperacute units were signifi-
cantly more likely than London HASUs to provide 4 of the 
interventions analyzed may relate to the ways in which London 
and Greater Manchester hyperacute units were designed and 
specified (eg, in terms of staffing and availability of allied ser-
vices, Greater Manchester’s use of the 4 hour eligibility cri-
terion, and the extent to which services had to operate a 24/7 
service) and how these specifications were implemented. The 
contrast in performance by PSCs in hours and out of hours 
is likely to reflect the differing specifications for hyperacute 
and nonhyperacute services applied at these times, including 
staffing levels and access to diagnostic services. In both areas, 
nonhyperacute units were less likely to provide interventions, 
reflecting an important consideration when centralizing ser-
vices. In London, only 7% of London patients were treated in 
SUs: this had a negligible effect, but may reflect issues where 
the referral protocol was not followed. In Greater Manchester, 
DSCs were less likely to provide the interventions analyzed; 
as DSCs treated 61% of Greater Manchester patients, Greater 
Manchester and comparator services performed similarly 
overall, suggesting the benefits of this centralization were lim-
ited. It should be noted that, to address these issues, Greater 
Manchester recently centralized its services further, imple-
menting a model more in line with the one used in London 
and originally planned in Greater Manchester. Finally, it is 
unlikely that geography influenced Greater Manchester patient 
eligibility significantly, given that the maximum distance from 
any point in Greater Manchester to the 24/7 Comprehensive 
Stroke Center is <25 miles.
Little is known about how large scale service centralization 
influences provision of evidence-based stroke clinical inter-
ventions, but there is substantial evidence that such clinical 
interventions are associated with better clinical outcomes, for 
example, through dedicated stroke units with specialist staff 
providing rapid assessment, treatment, and therapies.1,2,17–19 
Recent research indicates that the London centralization had 
a significantly greater impact on patient mortality than in the 
rest of England, whereas the Greater Manchester centraliza-
tion did not.4 The current analysis suggests that this difference 
might result from better access (on average) to evidence-based 
clinical interventions on arrival at hospital in London because 
of a higher proportion of patients being admitted to hyper-
acute units. This in turn suggests the model implemented is 
important: centralizing acute stroke services into a small num-
ber of hyperacute units can increase access to evidence-based 
clinical interventions, which may in turn lead to better clini-
cal outcomes. Further, the model selected may influence the 
extent to which it is followed: the Greater Manchester model 
may have been followed less reliably because of complexity 
associated with the 4-hour eligibility criterion for admission 
to hyperacute units and PSCs’ limited hours. This in turn sug-
gests potential advantages to service models that aim for rela-
tive simplicity. Therefore, our findings indicate that there may 
be significant benefits in models where all stroke patients are 
eligible for hyperacute unit admission: offering hyperacute 
unit admission selectively, for example, based on time of 
stroke onset, may limit these benefits. As the centralizations 
studied were implemented in large metropolitan areas, these 
findings are of greatest relevance to urban settings.
General increases in likelihood of patients receiving inter-
ventions, reflected in the comparator, should also be noted. 
These may reflect the influence of national drivers to improve 
stroke care across England, for example, the National Stroke 
Strategy13 and the ‘Stroke Best Practice Tariff’,20,21 increasing 
hospitals’ prioritization of clinical interventions measured in 
national stroke audits. This may contribute to the overall lower 
likelihood of Greater Manchester patients undergoing 4 of the 
interventions than comparator patients because our data indi-
cate comparatively limited improvements in DSC services, 
whereas general improvements occurred in many of the com-
parator services.
To study the impact of centralizing acute stroke services, 
we have been able to analyze 2 different models of centraliza-
tion implemented within the same national healthcare system 
at approximately the same time using data from 2 compre-
hensive national audits. This allowed us to compare findings 
between the 2 centralizations and with a large, urban compara-
tor, thus enhancing external validity. Our study has several 
limitations. First, because of variable participation in SINAP, it 
was not appropriate to use the rest of England as our compara-
tor; this limits the extent to which we may use these results 
to explain previous research on the impact of these centraliza-
tions on mortality. Second, it is possible that data completeness 
may have varied across hospitals in the Greater Manchester, 
London, and comparator areas, thus limiting the confidence 
with which we interpret the data analyzed. Third, because of 
data availability, several important clinical interventions could 
not be analyzed. Provision and timing of thrombolysis were 
excluded because in 2008 thrombolysis rates were not reported 
with sufficient frequency to permit reliable analysis. However, 
the stroke services analysed aim to treat all stroke patients, only 
a proportion of whom (≈16%)22 are eligible for thrombolysis. 
Other interventions excluded were anticoagulation of atrial 
fibrillation (data were not collected in either audit) and occu-
pational therapy assessment and continence assessment (cri-
teria assessed changed over time). Fourth, it was not possible 
to adjust for stroke severity (eg, using the National Institutes 
of Health Stroke Scale) because these data were not collected 
in either audit analyzed. However, it is recommended that 
stroke patients receive these interventions regardless of sever-
ity (unless contraindicated); therefore, controlling for sever-
ity should have little impact on whether these interventions 
are provided. However, the latest version of the audit collects 
National Institutes of Health Stroke Scale for all patients on 
arrival at hospital, and future research might usefully analyze 
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whether stroke severity influences likelihood of receiving inter-
ventions. Fifth, because the areas studied varied in overall per-
formance levels precentralization and several of the selected 
indicators approached ceiling both pre- and postcentralization, 
our analysis of change over time was limited. Sixth, it was not 
possible to control for hospital/unit effects because the num-
ber and function of stroke services changed significantly over 
the period studied. Finally, the analysis of patients presenting 
within 4 hours of their symptoms appearing was derived from 
SINAP data on time of stroke symptom onset: although we 
made every effort to exclude unreliable data, it remains that 
some may have been recorded unreliably.
Our data indicate both that the centralization model 
selected and the degree to which it was followed may have 
influenced the likelihood of stroke patients receiving evidence-
based clinical interventions and that these factors may be inter-
related. Therefore, qualitative analysis of how model selection 
and implementation processes influenced the development of 
hyperacute and nonhyperacute services, and the reliability with 
which patients were transferred to these services, is required 
to generate valuable lessons for future changes of this kind. 
Future research should analyze the impact of centralization 
on such outcomes as patient and carer experience, poststroke 
independence, disability, and quality of life. Finally, the cost 
and cost effectiveness of centralization should also be explored.
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SUPPLEMENTAL METHODS 
Process of selecting the comparator area 
Table I presents participation in Sentinel 2008 (pre-centralization) and SINAP (post-
centralization), organized by area (Greater Manchester, London, rest of England).  
Table I. Proportion of participating sites, by area and phase  
Region Proportion of sites participating in 
Sentinel 2008 (%) 
Proportion of sites participating 
in SINAP (%) 
Greater Manchester 12/12 (100%) 11/11 (100%) 
London 30/30 (100%) 24/24 (100%) 
Rest of England 147/147 (100%) 96/136 (70.6%) 
Sentinel 2008 had high levels of participation across all regions of England: it was estimated 
that all acute trusts admitting acute stroke patients took part in the audit. In SINAP, the 
proportion of sites participating across the Rest of England was considerably lower than in 
London and Greater Manchester. Given the different levels of participation in the before and 
after periods, we concluded that the rest of England would not represent a suitable control 
group for a before and after analysis.  
Table II presents participation in SINAP by region, in terms of 1) number of cases submitted 
to SINAP per head of local population and 2) the proportion of organisations submitting data 
to SINAP 
Table II. Numbers of cases submitted to SINAP by Region of England 
Region Population 
2011 
Total cases 
submitted 
Cases per 
100000  
Proportion of sites 
participating (%) 
1. East Midlands 4533222 3040 67.06 4/10 (40%) 
2. East of England 5846965 4261 72.88 11/17 (64.71%) 
3. London 8173941 16773 205.20 24/24 (100%) 
4. North East 2596886 7877 303.32 11/11 (100%) 
5. North West 7052177 24350 345.28 27/27 (100%) 
5a. Greater Manchester 2682500 10295 383.78 11/11 (100%) 
5b. Rest of North West England 4369677 14055 321.65 16/16 (100%) 
6. South East England 8634750 8813 102.06 19/28 (67.86%) 
7. South West 5288935 7431 140.50 8/18 (44.44%) 
8. West Midlands 5601847 5659 101.02 16/20 (80%) 
9. Yorkshire and the Humber 5283733 6680 126.43 11/16 (68.75%) 
England (total) 53012456 84884 160.12 131/171 (76.6%) 
Note. Population figures were drawn from 2011 UK census data.
3
 Total numbers of cases submitted were drawn 
from our analysis. Proportion of sites participating: the numerator was drawn from our analysis, and the  
denominator from publicly reported SINAP data.
4
 In line with our analysis, we report all 24 London sites 
submitting data to SINAP. 
This analysis shows that Greater Manchester and London had high levels of participation on 
both selected criteria, and well above the average for England. The only other areas with 
similar levels of participation were North East England and the rest of North West England 
(i.e. excluding Greater Manchester). Based on this analysis it was decided that the data from 
these areas should be used as the control group in both the pre- and post-centralization 
periods of the analyses, with data from other areas excluded. 
To ensure comparability with Greater Manchester and London, both of cover areas classified 
by the United Kingdom’s Office for National Statistics as ‘major urban’ (“districts with either 
100,000 people or 50% of their population in urban areas with a population of more than 
750,000”5), we limited services in the comparator to those serving populations classified by 
3 
 
the ONS as ‘major urban’. This was done by mapping locations of each service in the 
comparator and selecting those in districts classified as ‘major urban’. Details of cases 
included and excluded from the analysis are presented in table III. 
Table III. Summary of inclusion and exclusion of stroke cases in this analysis 
 Sentinel 2008 SINAP Total 
Greater Manchester 653 10,295 10,948 
London 1,541 16,773 18,314 
Urban comparator 537 9,044 9,581 
Excluded cases 7,341 48,772 56,113 
Total cases 10,072 84,884 94,956 
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SUPPLEMENTAL TABLES 
Risk-adjusted analyses with rest of England data acting as comparator 
Table III. Risk-adjusted proportions of patients receiving evidence-based clinical interventions: Greater Manchester versus rest of England 
Indicator Greater Manchester (% likelihood (95% confidence intervals]) 
Rest of England 
 Overall CSC/PSCs DSCs 
 Before After After After Before After 
Brain scan 3h 21.2% [17.6-24.8] 60.9% [60.0-61.8] 82.4% [81.3-83.6] 46.4% [45.2-47.7] 22.5% [21.6-23.3] 59.0% [58.7-59.4] 
Stroke Unit 4h 15.9% [13.0-18.9] 53.1% [52.1-54.0] 80.7% [79.6%-81.6] 33.2% [32.1-34.5] 18.7% [17.9-19.5] 56.9% [56.5-57.2] 
Brain scan 24h 68.2% [64.6-71.9] 93.0% [92.5-93.5] 97.8% [97.3-98.2] 89.9% [89.2-90.7] 62.1% [61.1-63.1] 91.8% [91.6-92.0] 
Antiplatelet 48h 86.5% [83.9-89.2] 93.9% [93.5-94.4] 97.5% [97.0-98.0] 91.9% [91.2-92.5] 85.4% [84.6-86.2] 91.7% [91.5-91.9] 
Physio 72h 88.0% [85.4-90.5] 91.7% [91.1-92.2] 93.4% [92.5-94.2] 90.9% [90.2-91.6] 85.0% [84.2-85.8] 92.8% [92.6-93.0] 
Nutrition 72h 88.2% [85.6-90.7] 94.9% [94.5-95.3] 98.1% [97.7-98.5] 92.8% [92.2-93.4] 69.6% [68.6-70.6] 91.4% [91.2-91.7] 
Swallow 72h 85.6% [82.0-89.2] 92.7% [92.2-93.1] 98.1% [97.7-98.5] 89.2% [88.4-89.9] 79.7% [78.6-80.8] 91.1% [90.9-91.4] 
Note. Patients treated in hospitals hosting PSCs only classed as being treated in hyperacute unit if arriving between 7am and 7pm, Monday - Friday; out of hours, these patients classed as being treated 
in a DSC. 
Table IV. Risk-adjusted proportions of patients receiving evidence-based clinical interventions: London versus rest of England 
Indicator 
London (% likelihood [95% confidence intervals]) 
Rest of England 
Overall HASUs SUs 
Before After After After Before After 
Brain scan 3h 36.1% [33.6-38.6] 72.0% [71.4-72.7] 74.4% [73.8-75.1] 39.1% [36.2-42.0] 19.4% [18.5-20.2] 56.6% [56.2-57.0] 
Stroke Unit 4h 30.8% [28.4-33.1] 67.9% [67.2-68.6] 70.5% [69.8-71.2] 30.9% [28.1-33.8] 15.7% [14.9-16.5] 54.2% [53.9-54.6] 
Brain scan 24h 77.1% [74.9-79.3] 95.1% [94.8-95.4] 96.1% [95.8-96.4] 82.5% [80.3-84.7] 59.3% [58.2-60.4] 91.3% [91.1-91.6] 
Antiplatelet 48h 94.2% [93.0-95.5] 94.9% [94.6-95.3] 95.4% [95.0-95.7] 89.9% [88.1-91.7] 83.8% [82.9-84.6] 91.6% [91.3-91.8] 
Physio 72h 90.4% [88.8-92.0] 96.0% [95.7-96.4] 96.6% [96.3-96.9] 88.8% [86.9-90.8] 83.8% [83.0-84.7] 92.1% [91.8-92.3] 
Nutrition 72h 74.6% [72.3-76.8] 98.4% [98.2-98.6] 98.6% [98.5-98.8] 94.6% [93.4-95.9] 70.0% [68.9-71.0] 90.6% [90.3-90.8] 
Swallow 72h 87.3% [85.0-89.6] 98.4% [98.2-98.6] 99.1% [99.0-99.3] 88.8% [86.8-90.7] 77.7% [76.5-79.0] 89.6% [89.3-89.8] 
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SUPPLEMENTAL TABLES 
Risk-adjusted analysis of impact of following referral protocol in Greater Manchester 
Table V. Risk-adjusted proportions of Greater Manchester DSC patients receiving evidence-based clinical interventions, depending on 
whether admitted within or beyond 4 hours after onset of symptoms 
 CSC/PSCs after DSCs after (% likelihood [95% confidence intervals]) 
Intervention Overall Overall 
Overall 
(where onset time 
available) 
≤4h >4h 
Brain scan 3h 84.6% (83.6-85.6) 50.7% [49.4-51.9] 53.8% [51.9-55.6] 59.4% [56.7-62.1] 49.2% [46.6-51.8] 
Stroke Unit 4h 81.4% (80.3-82.5) 34.1% [32.8-35.4] 38.4% [36.5-40.4] 36.6% [33.7-39.4] 40.2% [37.5-42.8] 
Brain scan 24h 98.0% (97.6-98.4) 90.9% [90.2-91.5] 93.4% [92.4-94.3] 94.3% [93.1-95.7] 92.5% [91.1-93.9] 
Antiplatelet 48h 97.6% (97.1-98.1) 92.1% [91.4-92.8] 94.0% [93.1-95.0] 93.3% [91.9-94.8] 94.7% [93.4-96.0] 
Physio 72h 93.5% (92.7-94.4) 91.1% [90.4-91.8] 92.3% [91.3-93.4] 92.3% [90.7-93.9] 92.4% [91.0-93.8] 
Nutrition 72h 98.3% (97.9-98.6) 93.3% [92.8-93.9] 92.8% [91.9-93.8] 92.7% [91.3-94.1] 93.0% [91.8-94.3] 
Swallow 72h 98.2% (97.9-98.6) 90.1% [89.4-90.8] 91.5% [90.5-92.5] 90.7% [89.2-92.3] 92.3% [91.0-93.6] 
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SUPPLEMENTAL TABLES 
Risk adjusted analysis of impact of time of arrival at hyperacute unit in Greater 
Manchester and London 
Table VI. Risk-adjusted proportions of London HASU patients receiving evidence-based 
clinical interventions, depending on whether admitted within or beyond 4 hours after 
onset of symptoms 
Indicator 
HASUs - after (% likelihood [95% confidence intervals]) 
Overall ≤4h >4h 
Brain scan 3h 74.6% [73.8-75.3] 91.4% [90.6-92.2] 68.7% [67.1-70.2] 
Stroke Unit 4h 69.1% [68.3-69.9] 80.1% [79.8-82.0] 64.7% [63.0-66.3] 
Brain scan 24h 96.2% [95.9-96.5] 98.9% [98.6-99.1] 96.4% [95.7-97.0] 
Antiplatelet 48h 95.3% [94.9-95.7] 94.9% [94.2-95.6] 96.4% [95.7-97.1] 
Physio 72h 96.0% [95.6-96.4] 95.6% [94.9-96.3] 96.1% [95.3-97.0] 
Nutrition 72h 98.6% [98.4-98.8] 98.7% [98.3-99.0] 99.0% [98.6-99.3] 
Swallow 72h 99.0% [98.8-99.1] 99.2% [98.9-99.5] 99.2% [98.8-99.5] 
 
Table VII. Risk-adjusted proportions of Greater Manchester CSC/PSCpatients receiving 
evidence-based clinical interventions, depending on whether admitted within or beyond 
4 hours after onset of symptoms 
Indicator 
CSC/PSC - after (% likelihood [95% confidence intervals]) 
Overall ≤4h >4h 
Brain scan 3h 85.5% [84.6-86.5] 92.7% [91.7-93.7] 83.1% [80.9-85.2] 
Stroke Unit 4h 82.9% [81.8-83.9] 90.1% [89.1-91.3] 83.5% [81.3-85.6] 
Brain scan 24h 98.2% [97.8-98.5] 99.4% [99.1-99.7] 98.2% [97.5-99.1] 
Antiplatelet 48h 97.6% [97.1-98.1] 98.3% [97.7-98.9] 98.2% [97.3-99.1] 
Physio 72h 93.8% [93.0-94.7] 93.4% [92.1-94.6] 95.6% [94.2-97.1] 
Nutrition 72h 98.5% [98.2-98.8] 98.9% [98.5-99.2] 98.5% [97.9-99.2] 
Swallow 72h 98.6% [98.2-98.9] 99.3% [99.0-99.6] 98.5% [98.0-99.2] 
 
Note. Overall figures drawn from full dataset, whereas ≤4h and >4h figures based on data where 
reliable symptom onset data were available. 
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SUPPLEMENTAL FIGURES 
Between-hospital variations by area (Greater Manchester, London, Comparator, rest of 
England), before and after centralization 
 
Overview: 
Figures I-IV: Proportion of patients undergoing brain scan within 3 hours 
Figures V-VIII: Proportion of patients admitted to stroke unit within 4 hours 
Figures IX-XII: Proportion of patients undergoing brain scan within 24 hours 
Figures XIII-XVI: Proportion of patients administered antiplatelet within 48 hours 
Figures XVII-XX: Proportion of patients receiving physiotherapist assessment within 72 
hours 
Figures XXI-XIV: Proportion of patients receiving nutrition assessment within 72 hours 
Figures XXV-XVIII: Proportion of patients receiving swallow assessment within 72 hours 
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Figure I. Proportion of patients undergoing brain scan within 3 hours: Greater 
Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure II. Proportion of patients undergoing brain scan within 3 hours: London 
A) Pre-centralization B) Post-centralization 
  
Figure III. Proportion of patients undergoing brain scan within 3 hours: Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure IV. Proportion of patients undergoing brain scan within 3 hours: rest of England 
A) Pre-centralization B) Post-centralization 
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Figure V. Proportion of patients admitted to stroke unit within 4 hours: Greater 
Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure VI. Proportion of patients admitted to stroke unit within 4 hours: London 
A) Pre-centralization B) Post-centralization 
  
Figure VII. Proportion of patients admitted to stroke unit within 4 hours: Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure VIII. Proportion of patients admitted to stroke unit within 4 hours: Rest of 
England 
A) Pre-centralization B) Post-centralization 
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Figure IX. Proportion of patients undergoing brain scan within 24 hours: Greater 
Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure X. Proportion of patients undergoing brain scan within 24 hours: London 
A) Pre-centralization B) Post-centralization 
  
Figure XI. Proportion of patients undergoing brain scan within 24 hours: Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure XII. Proportion of patients undergoing brain scan within 24 hours: Rest of 
England 
A) Pre-centralization B) Post-centralization 
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Figure XIII. Proportion of patients administered antiplatelet within 48 hours: Greater 
Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure XIV. Proportion of patients administered antiplatelet within 48 hours: London 
A) Pre-centralization B) Post-centralization 
  
Figure XV. Proportion of patients administered antiplatelet within 48 hours: 
Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure XVI. Proportion of patients administered antiplatelet within 48 hours: Rest of 
England 
A) Pre-centralization B) Post-centralization 
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Figure XVII. Proportion of patients receiving physiotherapist assessment within 72 
hours: Greater Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure XVIII. Proportion of patients receiving physiotherapist assessment within 72 
hours: London 
A) Pre-centralization B) Post-centralization 
  
Figure XIX. Proportion of patients receiving physiotherapist assessment within 72 
hours: Comparator 
A) Pre-centralization B) Post-centralization 
 
 
Figure XX. Proportion of patients receiving physiotherapist assessment within 72 
hours: rest of England 
A) Pre-centralization B) Post-centralization 
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Figure XXI. Proportion of patients receiving nutrition assessment within 72 hours: 
Greater Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure XXII. Proportion of patients receiving nutrition assessment within 72 hours: 
London 
A) Pre-centralization B) Post-centralization 
  
Figure XXIII. Proportion of patients receiving nutrition assessment within 72 hours: 
Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure XXIV. Proportion of patients receiving nutrition assessment within 72 hours: 
rest of England 
A) Pre-centralization B) Post-centralization 
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Figure XXV. Proportion of patients receiving swallow assessment within 72 hours: 
Greater Manchester 
A) Pre-centralization B) Post-centralization 
  
Figure XXVI. Proportion of patients receiving swallow assessment within 72 hours: 
London 
A) Pre-centralization B) Post-centralization 
  
Figure XXVII. Proportion of patients receiving swallow assessment within 72 hours: 
Comparator 
A) Pre-centralization B) Post-centralization 
  
Figure XXVIII. Proportion of patients receiving swallow assessment within 72 hours: 
rest of England 
A) Pre-centralization B) Post-centralization 
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